Company Research Report: Gavi, The Vaccine Alliance

Company Overview

• Name: Gavi, The Vaccine Alliance

• Mission: To save lives and protect people’s health by increasing equitable and sustainable use of vaccines.

• Founded and Founders: Established in 2000, the organization does not specify individual founders but was a collective initiative involving entities such as the Bill & Melinda Gates Foundation, WHO, UNICEF, and the World Bank.

• Key People: José Manuel Barroso (Board Chair), Dr. Sania Nishtar (CEO).

• Headquarters: Geneva, Switzerland.

• Number of Employees: No specific data available.

• Revenue: No specific data available.

• Known For: Gavi is recognized for its extensive efforts in increasing vaccine availability, accessibility, and uptake in lower-income countries, thereby vaccinating more than 1.1 billion children and averting over 18.8 million future deaths.

Products

Vaccines

• Vaccines Supported:

• COVID-19 Vaccines: Focuses on increasing global access to COVID-19 vaccines.

• Human Papillomavirus (HPV): Aims to protect against HPV infections which can lead to cervical cancer.

• Inactivated Polio Vaccine: Works towards the eradication of polio worldwide.

• Japanese Encephalitis, Measles, and Measles-Rubella, among others.

• Product Descriptions:

• Gavi supports 20 vaccines targeting infectious diseases including COVID-19, HPV, polio, and more.

• Provides funding for vaccine procurement and capacity building in immunisation supply chains.

• Key Features:

• Focus on equitable distribution, ensuring vaccines reach the most underserved populations.

• Collaboration with governments, the private sector, NGOs, and international bodies to boost vaccine development and deployment.

Recent Developments

• Recent Developments:

• Introduction of malaria vaccines in Sudan and the Democratic Republic of the Congo into routine immunization programs.

• Launch of a national measles-rubella vaccination campaign in Cambodia to protect over 1.5 million children.

• New Products Launched:

• Malaria vaccines have been rolled out in Sudan and the Democratic Republic of the Congo as part of routine immunization.

• New Features:

• Incorporation of new strategic goals focusing on zero-dose children and enhancing programmatic sustainability.

• Partnerships:

• Collaborations with WHO, UNICEF, the World Bank, and other bodies to support vaccine distribution and create supportive environments for immunization expansion.

Gavi continues to sustain its significant role in global health by adapting its product portfolio and strategies to meet emerging threats and health challenges worldwide.